Cessation of Anti-VEGF Treatment Therapy in Age-Related Macular Degeneration: A Narrative Review
{{output}}
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionised the treatment of neovascular age-related macular degeneration (nAMD), significantly improving visual outcomes and enhancing the quality of life for affected patients. H... ...
